Jazz Pharmaceuticals (JAZZ) Earnings Date & Reports

Industry: @Pharmaceuticals Other

A.I. Advisor

published Earnings

JAZZ is expected to report earnings to rise 4.34% to $5.53 per share on November 05

Jazz Pharmaceuticals JAZZ Stock Earnings Reports

Q3'24

Est.

$5.53

Q2'24

Beat

by $0.53

Q1'24

Missed

by $1.50

Q4'23

Missed

by $0.16

Q3'23

Missed

by $0.09

The last earnings report on July 31 showed earnings per share of $5.30, beating the estimate of $4.77. With 500.04K shares outstanding, the current market capitalization sits at 6.85B.

View a ticker or compare two or three

Compare

JAZZ

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For JAZZ
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for JAZZ (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Pharmaceuticals Other

Address

Waterloo Road

Phone

+353 16347800

Employees

2800

Web

https://www.jazzpharmaceuticals.com